Cycle for Survival | Search

Skip to main content

MedPath Trial Home

Organizations News Research

Data Sources:ClinicalTrials.govEU CTRFDAEMANMPATGAHealth CanadaWHO ICTRP

MedPath Trial Home

Search trials. Track pipelines. Understand approvals. With AI-powered intelligence for clinical research.

Product

Clinical Trials
Drug Intelligence
Global Approvals
AI Research
Pricing

Resources

FAQ
Search

Company

News
About
Contact

Legal

Privacy Policy
Terms of Service

Disclaimer: This website provides information retrieval and data analysis services. The content does not constitute medical advice. Eligibility assessments are for reference only and should not replace consultation with qualified healthcare professionals. Data is sourced from public registries and regulatory agencies; MedPath does not guarantee completeness or accuracy. Always verify information with primary sources.

© 2026 MedPath Trial. All rights reserved.

We value your privacy

We use cookies to analyze site traffic and improve your experience. See our Privacy Policy.

233,921 results for “Cycle for Survival”

Trials

View all 189666 →

Bioequivalence Study of Ritonavir Versus NORVIR in Healthy Chinese Subjects

96 participants · First posted Oct 5, 2017

Platelet Response During the Second Cycle of Decitabine Can Predict Response and Survival for Myelodysplastic Syndrome

1 participants · First posted Jan 27, 2014

Natural Cycle vs. Modified Natural Cycle vs. Artificial Cycle Protocol for Endometrial Preparation.

1,428 participants · First posted Mar 18, 2021

Drugs

View all 2301 →

CELL CYCLE(Odyssey)

N-epoxymethyl-1,8-naphthalimide (Agency For Science Technology & Research)

Urea cycle disorders(CAMP4 Therapeutics)

Organizations

View all 1237 →

CYCLE PHARMACEUTICALS LTD

United Kingdom

Cycle Pharmaceuticals Ltd.

United States

THOMPSON CANCER SURVIVAL CENTER

United States

News

View all 40717 →

Cycle Pharmaceuticals Launches VENXXIVA for Cystinuria Treatment in the US

Vivo Capital Secures $740 Million for Third Cycle of Healthcare Investment Fund

Endo Launches First Generic Version of RAVICTI for Rare Urea Cycle Disorders

Page 1 of 23393